Works about ANGIOTENSIN II


Results: 5000
    1
    2
    3
    4
    5
    6
    7
    8
    9
    10
    11
    12
    13
    14
    15
    16
    17
    18
    19
    20
    21
    22
    23

    Randomized trial of an increased dose of calcium channel blocker or angiotensin II type 1 receptor blocker as an add-on intensive depressor therapy in type 2 diabetes mellitus patients with uncontrolled essential hypertension: the ACADEMIE Study.

    Published in:
    Heart & Vessels, 2019, v. 34, n. 4, p. 698, doi. 10.1007/s00380-018-1286-2
    By:
    • Imaizumi, Satoshi;
    • Shiga, Yuhei;
    • Ogawa, Masahiro;
    • Sako, Hideto;
    • Nagata, Yoshihisa;
    • Matsunaga, Akira;
    • Shirotani, Tetsuro;
    • Hoshino, Fumihiro;
    • Yahiro, Eiji;
    • Uehara, Yuko;
    • Morito, Natsumi;
    • Tanigawa, Hiroyuki;
    • Shimono, Dai;
    • Fukushima, Mikio;
    • Sugihara, Hidekazu;
    • Norimatsu, Kenji;
    • Kusumoto, Takaaki;
    • Saku, Keijiro;
    • Miura, Shin-ichiro
    Publication type:
    Article
    24
    25
    26
    27
    28
    29

    Atrial natriuretic peptide exerts protective action against angiotensin II-induced cardiac remodeling by attenuating inflammation via endothelin-1/endothelin receptor A cascade.

    Published in:
    Heart & Vessels, 2013, v. 28, n. 5, p. 646, doi. 10.1007/s00380-012-0311-0
    By:
    • Fujita, Shuichi;
    • Shimojo, Naoshi;
    • Terasaki, Fumio;
    • Otsuka, Kaoru;
    • Hosotani, Noriko;
    • Kohda, Yuka;
    • Tanaka, Takao;
    • Nishioka, Tomohiro;
    • Yoshida, Toshimichi;
    • Hiroe, Michiaki;
    • Kitaura, Yasushi;
    • Ishizaka, Nobukazu;
    • Imanaka-Yoshida, Kyoko
    Publication type:
    Article
    30
    31
    32
    33
    34
    35
    36
    37
    38
    39
    40
    41
    42
    43
    44
    45
    46
    47
    48
    49
    50